// App-Quantinova.ai

Su1863 : EVALUATION OF SAFETY AND EFFICACY OF ANTITNF_ TREATMENT AMONG 11275 PREGNANCIES OCCURRING IN 8726 WOMEN WITH IN INFLAMMATORY BOWEL DISEASES. STUDY ON THE FRENCH NATIONAL HEALTH INSURANCE DATABASE

Researchers

Presenter

  • Eric Benzenine

Principal Investigators

  • Muriel Doret

  • Christophe Michiels

  • Alan N. Barkun

  • Catherine Quantin

  • Marc Bardou

Medical Centers

  • Biostatistics and Information department, CHU Dijon-Bourgogne, Dijon, France

  • Biostatistics Department, Hospices Civils de Lyon, Lyon, France

  • UFR Sciences Sante, Universite de Bourgogne, Dijon, France

  • CIC-P INSERM, CHU Dijon-Bourgogne, Dijon, France

  • Gastroenterology Department, CHU Dijon-Bourgogne, Dijon, France

  • Gastroenterology, Mc Gill University Health Center, Montreal, Quebec, Canada

Locations

  • France

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Adalimumab

  • Infliximab

Outcome

  • Unknown

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved